Interventions for Tuberculosis Control and Elimination 2002

410. Paradelis AG, Triantaphyllidis C, Giala MM. Neuromuscular blocking activity
of aminoglycoside antibiotics. Meth Find Exptl Clin Pharmacol 1980; 1: 45-51.
411. Ohtani I, Ohtsuki K, Omata T, Ouchi J, Saito T. Potentiation and its mechansims
of cochlear damage resulting from furosemide and aminoglycoside antibiotics.
J Otorhinlaryngol Relat Spec 1981; 40: 53-63.
412. Mathog RH, Capps MJ. Ototoxic interactions of ethacrynic acid and streptomycin.
Ann Otol 1977; 86: 158-63.
413. Steinbereithner K. Synergistische Wirkung bestimmter Antibiotika mit
Muskelrelaxantien vom Curaretyp. Bull Schweiz Med Wiss 1967; 23: 57-68.
414. Giala MM, Paradelis AG. Two cases of prolonged respiratory depression due
to interaction of pancuronium with colistin and streptomycin.
J Antimicrob Chemother 1979; 5: 234-5.
(Correspondence).
415. Burkett L, Bikhazi GB, Thomas KC, Jr, Rosenthal DA, Wirta MG, Foldes FF.
Mutual potentitiation of the neuromuscular effects of antibiotics and relaxants.
Anesth Analg 1979; 58: 107-15.
416. Trubuhovich RV. Delayed reversal of diallyl-nortroxiferine after streptomycin.
(Correspondence). Br J Anaesth 1966; 38: 843-4.
417. Fréour P, Nacef T, Fourcaud R, Belhassime T, Kissel M. Le prothionamide dans
le traitement de la tuberculose pulmonaire.
Conference of IUATLD, 1969; 29-32.
New York: Proceedings of the 20th
418. Eule H. Les thioamides in vitro et en clinique. Résistance bactérienne et résistance
croisée. Leur place actuelle dans le traitement de la tuberculose. New
York: Proceedings of the 20th Conference of IUATLD, 1969; 25-8.
419. Domagk G. Investigations on the antituberculous activity of the thiosemicarbazones
in vitro and in vivo. Am Rev Tuberc 1950; 61: 8-19.
420. Domagk G, Behnisch R, Mietzsch F, SChmidt H. Ueber eine neue, gegen
Tuberkelbazillen in vitro wirksame Verbindungsklasse.
33: 315.
Naturwissenschaften 1946;
421. Malluche H. Die Thiosemicarbazone-Therapie der Tuberkulose. Fortschr Tuberk
Forsch 1952; 5: 152-254.
422. Grosset J, Benhassine M. La thiacétazone (TB1): données expérimentales et
cliniques récentes. Adv Tuberc Res 1970; 17: 107-53.
423. Thomas KL, Joseph S, Subbaiah TV, Selkon JB. Identification of tubercle bacilli
from Indian patients with pulmonary tuberculosis.
1961; 25: 747-58.
Bull World Health Organ
424. Mitchison DA, Lloyd J. Comparison of the sensitivity to thiacetazone of tubercle
bacilli from patients in Britain, East Africa, South India and Hong Kong.
Tubercle 1964; 45: 360-9.
425. Rist N. Thiacetazone sensitivity and resistance: introductory remarks. Tubercle
1968; 49 (suppl): 36-8.
196